|
|||||
|
|
| Clinical and economic outcomes associated with the use of fluticasone propionate 250?mcg and salmeterol 50?mcg combination versus tiotropium bromide 18?mcg as initial maintenance treatment for chronic obstructive pulmonary disease in managed care | |
| 摘 要： | |